Johnson & Johnson Press Releases

JNJ 
$102.11
*  
0.09
0.09%
Get JNJ Alerts
*Delayed - data as of Jul. 25, 2014  -  Find a broker to begin trading JNJ now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Johnson & Johnson Announces $5 Billion Share Repurchase Program
7/21/2014 5:00:00 PM - PR Newswire

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2014
7/21/2014 11:10:00 AM - PR Newswire

Johnson & Johnson Reports 2014 Second-Quarter Results:
7/15/2014 7:45:00 AM - PR Newswire

Cordis Corporation Launches SABER™ PTA Dilatation Catheter to Complement Portfolio of Peripheral Arterial Disease Treatments
7/1/2014 9:00:00 AM - Business Wire

Johnson & Johnson Completes Divestiture Of Ortho-Clinical Diagnostics To The Carlyle Group
6/30/2014 4:30:00 PM - PR Newswire

CARE WITH PRIDE™ On Target To Deliver More Than $500K to LGBT Charities
6/25/2014 9:30:00 AM - PR Newswire

Jennifer Doudna, Ph.D., and Emmanuelle Charpentier, Ph.D., Win 2014 Dr. Paul Janssen Award for Biomedical Research
6/24/2014 9:30:00 AM - PR Newswire

CEO and Chairman of UPS, D. Scott Davis, Joins Johnson & Johnson Board of Directors
6/19/2014 8:00:00 AM - PR Newswire

Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
6/17/2014 5:00:00 PM - PR Newswire

Health Care Sector Equities Coverage -- Research on Johnson and Johnson, Medicines Co., Merck, and Novo Nordisk
6/13/2014 7:40:00 AM - PR Newswire

Johnson & Johnson Announces U.S. "Champions of Care" as Part of 2014 FIFA World Cup Brazil™ Sponsorship
6/5/2014 12:30:00 PM - PR Newswire

LISTERINE® Brand Celebrates the FIFA World Cup™ Tournament through its Largest Global Social Media Activation
6/5/2014 9:00:00 AM - PR Newswire

Johnson & Johnson Reinforces Importance of Children Learning the Value of Care from their Parents as Part of CARE INSPIRES CARE™ Program
6/4/2014 3:01:00 PM - PR Newswire

DECN's Pharma Tech Subsidiary Places Significant Order for 50,000 Units of Genstrip 50 for Immediate Delivery to Select U.S. and International Distributors
6/3/2014 9:20:00 AM - Market Wire

Decision Diagnostics Corp. Subsidiary Pharma Tech Enters International Markets With Conformité Européenne (CE) Mark Submission
5/28/2014 9:20:00 AM - Market Wire

Nodality, Inc. Announces Publication of Promising Data in Melanoma in Journal of Translational Medicine
5/28/2014 8:00:00 AM - Business Wire

Johnson & Johnson Medical Devices & Diagnostics Businesses Expanding Market Leadership with Innovative Products and Customer-Focused Solutions
5/22/2014 8:45:00 AM - PR Newswire

Market Movers - Health Care Sector Stocks -- Research on VCA Antech, MEDNAX, Lannett, and Johnson & Johnson
5/21/2014 11:27:00 AM - PR Newswire

Janssen Announces Expanded Collaboration with International Partnership for Microbicides for Development and Commercialization of Dapivirine for Prevention of Sexual Transmission of HIV
5/8/2014 4:00:00 AM - PR Newswire

Johnson & Johnson Announces U.S. "Champions of Care" Program Finalists as Part of 2014 FIFA World Cup Brazil™ Sponsorship
5/5/2014 3:54:00 PM - PR Newswire

Johnson & Johnson and American College of Sports Medicine Form Global Alliance to Advance Human Health and Performance
4/30/2014 8:00:00 AM - PR Newswire

Technical Briefing on Equities Reaching New high -- Research on Johnson & Johnson, Berkshire Hathaway, HollyFrontier, and Crown Holdings
4/29/2014 12:03:00 PM - PR Newswire

Johnson & Johnson Announces New Collaboration with Stop TB Partnership's Global Drug Facility to Enhance Access to Anti-TB Compound
4/29/2014 8:30:00 AM - PR Newswire